Beijing Tong Ren Tang Chinese Medicine 過去の業績
過去 基準チェック /16
Beijing Tong Ren Tang Chinese Medicineは、平均年間1.6%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間5.7% 3.8%収益成長率で 成長しています。 Beijing Tong Ren Tang Chinese Medicineの自己資本利益率は13.4%であり、純利益率は35.9%です。
主要情報
1.6%
収益成長率
1.6%
EPS成長率
Pharmaceuticals 業界の成長 | 5.6% |
収益成長率 | 3.8% |
株主資本利益率 | 13.4% |
ネット・マージン | 35.9% |
前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up
Oct 04Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders
Sep 06Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?
Sep 02Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk
Feb 05Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Jan 03A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Sep 28Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today
Jul 12Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?
Mar 29Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28
Apr 28Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28
Mar 25Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?
Oct 27Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 28Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Mar 11What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 04Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?
Jan 18Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?
Dec 29Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Dec 11Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 23収支内訳
収支内訳
Beijing Tong Ren Tang Chinese Medicine の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
30 Jun 24 | 1,377 | 494 | 448 | 0 |
31 Mar 24 | 1,451 | 517 | 440 | 0 |
31 Dec 23 | 1,525 | 540 | 431 | 0 |
30 Sep 23 | 1,721 | 619 | 408 | 0 |
30 Jun 23 | 1,918 | 697 | 384 | 0 |
31 Mar 23 | 1,824 | 672 | 366 | 0 |
31 Dec 22 | 1,731 | 646 | 348 | 0 |
30 Sep 22 | 1,605 | 601 | 343 | 0 |
30 Jun 22 | 1,478 | 555 | 337 | 0 |
31 Mar 22 | 1,517 | 582 | 343 | 0 |
31 Dec 21 | 1,556 | 608 | 349 | 0 |
30 Sep 21 | 1,504 | 595 | 343 | 0 |
30 Jun 21 | 1,452 | 583 | 337 | 0 |
31 Mar 21 | 1,384 | 563 | 324 | 0 |
31 Dec 20 | 1,315 | 542 | 311 | 0 |
30 Sep 20 | 1,246 | 483 | 314 | 0 |
30 Jun 20 | 1,178 | 424 | 317 | 0 |
31 Mar 20 | 1,305 | 490 | 340 | 0 |
31 Dec 19 | 1,433 | 556 | 364 | 0 |
30 Sep 19 | 1,505 | 594 | 376 | 0 |
30 Jun 19 | 1,577 | 632 | 387 | 0 |
31 Mar 19 | 1,546 | 601 | 378 | 0 |
31 Dec 18 | 1,514 | 581 | 381 | 0 |
30 Sep 18 | 1,466 | 552 | 373 | 0 |
30 Jun 18 | 1,402 | 540 | 340 | 0 |
31 Mar 18 | 1,330 | 516 | 335 | 0 |
31 Dec 17 | 1,266 | 490 | 314 | 0 |
30 Sep 17 | 1,212 | 469 | 309 | 0 |
30 Jun 17 | 1,166 | 449 | 301 | 0 |
31 Mar 17 | 1,134 | 444 | 284 | 0 |
31 Dec 16 | 1,084 | 420 | 272 | 0 |
30 Sep 16 | 1,063 | 431 | 247 | 0 |
30 Jun 16 | 1,028 | 410 | 237 | 0 |
31 Mar 16 | 1,002 | 380 | 239 | 0 |
31 Dec 15 | 970 | 354 | 232 | 0 |
30 Sep 15 | 939 | 337 | 236 | 0 |
30 Jun 15 | 881 | 320 | 226 | 0 |
31 Mar 15 | 834 | 304 | 216 | 0 |
31 Dec 14 | 761 | 287 | 201 | 0 |
30 Sep 14 | 733 | 286 | 173 | 0 |
30 Jun 14 | 699 | 267 | 167 | 0 |
31 Mar 14 | 652 | 249 | 156 | 0 |
31 Dec 13 | 614 | 220 | 157 | 0 |
質の高い収益: 3613 非現金収入 のレベルが高いです。
利益率の向上: 3613の現在の純利益率 (35.9%)は、昨年(36.4%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 3613の収益は過去 5 年間で年間1.6%増加しました。
成長の加速: 3613は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: 3613は過去 1 年間で収益成長率がマイナス ( -29.1% ) となったため、 Pharmaceuticals業界平均 ( 9.4% ) と比較することが困難です。
株主資本利益率
高いROE: 3613の 自己資本利益率 ( 13.4% ) は 低い とみなされます。